Martin-Lujan Francisco, Santigosa-Ayala Antoni, Piñol-Moreso Josep-Lluis, Sorli-Aguilar Mar, Flores-Mateo Gemma, Bladé-Creixenti Jordi, Basora-Gallisà Josep, Sola-Alberich Rosa
Study Group on Respiratory Tract Diseases (GEPAR), Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), Barcelona, Spain.
School of Medicine and Health Sciences, Universitat Rovira i Virgili, Tarragona, Spain.
BMC Fam Pract. 2016 Feb 4;17:15. doi: 10.1186/s12875-016-0415-1.
Spirometry is the recommended method of evaluating pulmonary function when respiratory disease is suspected in smokers. Nonetheless, no evidence exists of the usefulness of information obtained from this test as a motivational strategy for smoking cessation. The primary objective of this study is to evaluate the effectiveness of a motivational intervention based on spirometry results in achieving long-term smoking cessation.
METHODS/DESIGN: We propose a multicenter randomized clinical trial in the primary care setting.
We will recruit active smokers of both sexes, aged 35-70 years, with a cumulated smoking habit exceeding 10 packs/year and who consult for any reason with their primary care physician in the 20 health centers in the province of Tarragona (Spain). Patients with a history of lung disease or who have undergone exploratory measures of pulmonary function in the preceding 12 months will be excluded. All patients who agree to participate will provide signed informed consent prior to their inclusion. A total of 1000 smokers will be consecutively randomized to a control or intervention group (1:1).
Participants in both groups will receive brief (5-minute) health counseling, in accordance with usual clinical practice. In a consultation lasting about 15 minutes, participants in the intervention group will also receive detailed, personalized information about the results of a spirometry test and about their lung age compared with their chronological age. Both groups will be followed up for 12 months. Main variables and analysis: The main variable will be sustained smoking abstinence at 12 months after the intervention, as confirmed by CO breath testing and urine cotinine test. Results will be analyzed based on intention to treat, using the chi-square test and logistical regression if necessary to adjust for confounding variables.
We expect the rate of prolonged smoking abstinence in the intervention group will be at least 5% higher than in the control group. If this strategy proves effective, it could easily be included in the health promotion activities offered in primary care settings.
ClinicalTrials.gov Identifier: NCT02153047 . Registered on 28/05/2014.
当怀疑吸烟者患有呼吸系统疾病时,肺功能测定是评估肺功能的推荐方法。然而,尚无证据表明通过该测试获得的信息作为戒烟的激励策略是否有用。本研究的主要目的是评估基于肺功能测定结果的激励干预措施在实现长期戒烟方面的有效性。
方法/设计:我们提议在初级保健机构中进行一项多中心随机临床试验。
我们将招募年龄在35至70岁之间、累积吸烟量超过每年10包且因任何原因在西班牙塔拉戈纳省的20个健康中心咨询其初级保健医生的男女吸烟者。有肺部疾病史或在过去12个月内接受过肺功能探索性检查的患者将被排除。所有同意参与的患者在纳入研究前将签署知情同意书。总共1000名吸烟者将被连续随机分为对照组或干预组(1:1)。
两组参与者都将按照常规临床实践接受简短(5分钟)的健康咨询。在一次持续约15分钟的咨询中,干预组的参与者还将收到关于肺功能测定测试结果以及与实际年龄相比的肺龄的详细个性化信息。两组都将接受12个月的随访。主要变量及分析:主要变量将是干预后12个月经一氧化碳呼气试验和尿可替宁试验确认的持续戒烟情况。结果将基于意向性分析进行分析,并在必要时使用卡方检验和逻辑回归来调整混杂变量。
我们预计干预组的长期戒烟率将比对照组至少高5%。如果该策略被证明有效,它可以很容易地纳入初级保健机构提供的健康促进活动中。
ClinicalTrials.gov标识符:NCT02153047。于2014年5月28日注册。